Eli Lilly Secures Global Rights to AlzeCure Neurodegenerative Assets
Eli Lilly Secures Global Rights to AlzeCure Neurodegenerative Assets Lilly wants the brain. They already dominate the metabolic market. Now…
Author: Chloe Summers
The Silicon Power Shift Reclaiming the AI Throne
The GPU era is peaking. The orchestration era has begun. For three years, the market worshipped at the altar of…
The SpaceX Liquidity Trap
The rockets are landing. The spreadsheets are burning.SpaceX is finally moving toward the public ledger. For years, retail investors chased…
Wall Street Gathers to Price the Cost of Resilience
The Reckoning at the InterContinentalThe lights are bright. The balance sheets are dim. Morgan Stanley kicked off its annual U.S.…
The Great Housing Thaw
The American housing market just broke its winter fever. May sales figures reached heights not seen since last December. This…
The Four Hundred Thousand Dollar Crib Debt
The Price of a Degree is a MortgageThe math is broken. A child born today faces a $400,000 price tag…
The Pacific Ocean Holds the Last Sustainable Tuna Monopoly
The Last Bastion of Blue GoldGlobal oceans are failing. Industrial overfishing has gutted the Atlantic and Indian basins. The Western…
The Last Blue Frontier of Sustainable Protein
The oceans are emptyingMost of them. Except for a specific patch of the Pacific. The Western and Central Pacific Ocean…
Marvell Technology and the S&P 500 Inclusion Premium
The Index Effect and the Marvell ArbitrageThe tape does not lie. Passive flows are coming. The smart money is already…
Wall Street Sells Access While Alpha Dissolves
The Institutional Myth of the Exceptional CEOThe marketing is slick. Morgan Stanley recently promoted its Exceptional Leaders series as a…